Steve Kelly and the other panelists discuss their paper titled “Assessing the policy and access environment across European countries for SMA patients.”
For more information on this event, click here.
From ASP to MFP: The looming disruption of the medical benefit
Key recent developments in the program include: The first two years of the MDPNP only covered retail-dispensed therapies but starting in this selection...